| Literature DB >> 32526879 |
Filipa Antunes1, Sara Marçal1, Oludemi Taofiq2, Alcina M M B Morais1, Ana Cristina Freitas1, Isabel C F R Ferreira2, Manuela Pintado1.
Abstract
Nowadays, the food sector is highly concerned with environmental issues and foreseen to develop strategies to reduce waste and losses resulting from activities developed in the food system. An approach is to increment added value to the agro-industrial wastes, which might provide economic growth and environmental protection, contributing to a circular economy. Mushroom by-products represent a disposal problem, but they are also promising sources of important compounds, which may be used due to their functional and nutritional properties. Research has been developed in different fields to obtain value added solutions for the by-products generated during mushroom production and processing. Bioactive compounds have been obtained and applied in the development of nutraceutical and pharmaceutical formulations. Additionally, other applications have been explored and include animal feed, fertilizer, bioremediation, energy production, bio-based materials, cosmetics and cosmeceuticals. The main purpose of this review is to highlight the relevant composition of mushroom by-products and discuss their potential as a source of functional compounds and other applications. Future research needs to explore pilot and industrial scale extraction methods to understand the technological feasibility and the economic sustainability of the bioactive compounds extraction and valorization towards different applications.Entities:
Keywords: applications; bioactive compounds; mushroom by-products; valorization
Mesh:
Substances:
Year: 2020 PMID: 32526879 PMCID: PMC7321189 DOI: 10.3390/molecules25112672
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic diagram of the mushroom production techniques, main products derived from production and potential applications. Adapted from [1,12].
Figure 2Mushroom by-products obtained by solid substrate fermentation only. (A) and (B) are mushroom production wastes (stipes and mushrooms that do not comply with commercial standards in terms of caliber, shape or size: 5–20% of the production weight); (C) by-products (surplus production: ≤ 5%); (D) spent mushroom substrate (>20% of the production weight). The photos were graciously supplied by Voz da Natureza.
Figure 3Main bioactive compounds in mushroom by-products and extraction methods involved in the extraction of bioactive compounds from mushroom by-products.
Extraction methods of polysaccharides and glycoproteins from by-products obtained by solid substrate fermentation and submerged liquid fermentation.
| Production Technique | Species | By-Products | Bioactive Compound | Extraction Method | Fractionation and Purification | Bioactivities | Reference |
|---|---|---|---|---|---|---|---|
| Solid Substrate Fermentation |
| Dried and powder caps and stipes | Chitin | Alkali treatment (2 M sodium hydroxide, 2 h at 100 °C); | nd | Antimicrobial activity | [ |
| Dried and powder caps and stipes | Beta-glucan | Ultrasound-assisted extraction; | nd | nd | [ | ||
| Dried and powder stipes | Chitosan | Precipitation with 96% ethanol; | nd | Good film-forming properties with antimicrobial activity | [ | ||
| Dried and powder stipes | Chitin-glucan complex | Alkali treatment (1 M sodium hydroxide, 95 °C, reflux 30 min); | nd | nd | [ | ||
|
| SMS | Polysaccharide | Hydrochloric acid extraction (0.5 M, 1:10, | Sevag method | Antioxidant activity; hypoglycemic and renoprotective effects | [ | |
|
| Dried and powder mycelium from SMS | Polysaccharide | Hot water extraction (1:20 | Sevag method; Dialysis; | Antitumor activity | [ | |
|
| Dried and powder SMS | Polysaccharide | Water extraction (1:35 ( | Sevag method; DEAE cellulose colum; Sephadex G-100 size-exclusion chromatography. | Antioxidant activity | [ | |
|
| Stipe | Lectin | Sodium chloride concentration, 0.50; liquid−solid | Dialysis; | Agglutinating activity | [ | |
|
| SMS | Lentinan | Hot water extraction (80 °C for 1 h); | Sevag method; | Antibacterial activity | [ | |
|
| Dried and powder SMS | Polysaccharide | Hot water extraction (1:20 ( | Deproteinization–combination of Sevag method and enzymatic hydrolysis (papain); | Antioxidant activity | [ | |
|
| SMS | Heteropolysaccharide (mainly composed of xylose, glucose and arabinose) | Alkali treatment (0.5 M NaOH, 90 °C for 300 min); | Sevag method | Antioxidant activity | [ | |
|
| Dried and powder mycelium from SMS and fruiting bodies | Polysaccharide | Precipitation with 85% ethanol; | Dialysis; | Antioxidant activity | [ | |
|
| Dried and powder mycelium from SMS and fruiting bodies | Heteropolysaccharide (mainly composed of glucose) | Precipitation with 85% ethanol at room temperature for 12 h; | Sevag method; | Antitumor activity | [ | |
| Submerged Liquid Fermentation |
| Fermentantion broth and mycelium | Polysaccharide | Hot water extraction (boiling, 1 h); | DEAE column; | nd | [ |
|
| Mycelium | Antrodan | Supercritical Fluid Extraction (reflux 3 times, 90 °C for 2 h); | Gel Permeation Chromatography (Sephadex G-100 Column) | Anti-inflammatory activity | [ | |
|
| Mycelium | Polysaccharide | Microwave for 3 min; Hot water extraction (1:2 | Sevag method; | Antioxidant activity | [ | |
|
| Mycelium | Glycoprotein | Extraction with water (4 °C); | Dialysis; | Antitumor activity | [ | |
|
| Mycelium | Polysaccharide (heteroglycan) | Hot water extraction (70 °C for 12 h); | Hollow-fiber ultrafiltration; | Antichronic atrophic gastritis activity | [ | |
|
| Mycelium | 12b-hydroxyverruculogen TR-2, fumitremorgin C and methylthiogliotoxin, two hetero-spirocyclic glactam alkaloids, pseurotin A and FD-838 and cerevisterol and herierin IV | Ultrasound assisted extraction with ethyl acetate. | Column chromatography over silica gel | Antioxidant and antifungal activities | [ | |
|
| Fermentation broth and mycelium | Polysaccharide | Fermentation broth:Extraction with 95% ( | Sevag method; | Antioxidant and immunomodulator properties | [ | |
|
| Fermentation broth and mycelium | Polysaccharide | Fermentation broth: | Fermentation broth: | Antioxidant activity | [ | |
|
| Fermentation broth and dried mycelium powder | Polysaccharide | Ethanol precipitation; | nd | Antitumor and antioxidant activities | [ | |
|
| Fermentation broth | Exopolysaccharides | Centrifugation at 3000 rpm for 20 min from the culture; | Dialysis; | Immunomodulatory activity | [ | |
|
| Mycelium | Proteoglycan | Phosphate-buffered saline treatment and centrifugation (8000 rpm for 15 min); | Dialysis; | Antitumor activity | [ | |
|
| Mycelium | Polysaccharide | Hot water extraction (100 °C for 3 h); | Dialysis (2 days) | Antitumor activity | [ | |
|
| Fermentation broth | Exopolysaccharide | Absolute ethanol precipitation. | Sevag method; | Anti-inflammatory activity | [ | |
|
| Fermentation broth | Tramesan (Exopolysaccharide) | Precipitation with ethanol; | Dialysis; | Antioxidant activity | [ | |
|
| Fermentation broth | Exopolysaccharides | Absolute ethanol precipitation | nd | nd | [ | |
|
| Fermentation broth | Polysaccharide | Gradient ethanol precipitation (40%, 50% and 80%, 4 °C, overnight) | nd | Antioxidant activity | [ |
nd—not determined.
Polyphenols and related compounds obtained from mushroom by-products.
| Production Technique | Species | By-Products | Bioactive Compound | Extraction Method | Bioactivities | Reference |
|---|---|---|---|---|---|---|
| Submerged Liquid Fermentation |
| Mycelia | Gallic, | Extraction with methanol:water (80:20, | Antioxidant | [ |
| mycelia and culture media | Extraction with methanol at 25 °C, 150 rpm for 1 h. | Anti-inflammatory | [ | |||
|
| Fermentation Broth, Mycelia | Gallic, ferulic, Epigallocatechin gallate, Phelligridin G, Davallialactone and Inoscavin B | Fermentation Broth -Extraction with 95% ethanol (1:4, | Antioxidant | [ | |
|
| Fermentation Broth, Mycelia | Epicatechin-3-gallate, epigallocatechin-3-gallate, phelligridin G, davallialactone and inoscavin B | Fermentation Broth -Extraction with 95% ethanol (1:4, | DPPH radical scavenging | [ | |
|
| Mycelia | Kaempferol, quercetin, isorhamnetin, luteolin, naringenin, apigenin, fortuneletin | Mycelial biomass was dried in a microwave oven for 10 min, extracted with 95% ethanol and stored at 4 °C overnight Centrifugation at 4500× | Superoxide and DPPH radical Scavenging | [ | |
|
| Mycelia | Protocatechuic and | Extracted with methanol:water (80:20, | Antioxidant | [ | |
|
| Mycelia and culture media | Extracted with methanol at 25 °C, 150 rpm for 1 h. | Anti-inflammatory | [ | ||
|
| Mycelia | Cinnamic acid | Extracted with ethanol (70%) at 25 °C and at 130 rpm for 3 h. | Antioxidant | [ | |
|
| Mycelia and culture media | Extracted with methanol at 25 °C, 150 rpm for 1 h. | Anti-inflammatory | [ | ||
| Solid Substrate Fermentation |
| Dried powder | Shikmic, chlorogenic, syringic, | Extraction with methanol (80%) and ethanol (80%) at 50 °C for 4 h. Refluxing at 40 °C, at 150 rpm for 4 h. Centrifuged at 15,000× | Antioxidant activities | [ |
|
| Substrate | Chlorogenic, syringic, ferulic, | Extraction in 80% methanol under sonication for 8 h. | Antioxidant activity | [ | |
|
| Substrate | Chlorogenic, syringic, ferulic, | Extraction in 80% methanol under sonication for 8 h. | Antioxidant activity | [ |
Other bioactives and related metabolites obtained from mushroom by-products.
| Part A—Triterpenes and Steroidal Compounds Obtained from Mushroom By-Products | |||||||
|---|---|---|---|---|---|---|---|
| Production Technique | Species | By-Products | Bioactive Compound | Extraction Method | Fractionation and Purification | Bioactivity | Reference |
| Submerged Liquid Fermentation |
| mycelia | betulin, ergosterol, cholesterol, lanosterol, stigmasterol and sitosterol | Ultrasonic extraction with methanol for 2 h. | nd | nd | [ |
|
| dry matter culture broth | Ergosterol, cholesterol, lanosterol and β-sitosterol | Extracted with 80% ethanol at room | nd | In vivo antioxidantAnti-cholesteremic | [ | |
|
| Fermentation Broth, Mycelia | (22 | Extraction with hexane, chloroform, ethyl acetate and methanol three times for 12 h at room temperature | Fractionated on a silica gel column yielding four fractions further separated using a | Dipeptidyl peptidase-4 inhibitory activity | [ | |
| Solid Substrate Fermentation |
| Fruiting body | Ergosterol | Microwave-assisted extraction with ethanol at 19.4 ± 2.9 min,132.8 ± 12.4 °C and 1.6 ± 0.5 g/L | nd | nd | [ |
|
| sclerotia | lanosterol, 3β-hydroxy-lanosta-8,24-diene-21-al, inotodiol, ergosterol peroxide and trametenolic acid | Extracted three times with ethanol at 78 °C. | nd | Anti-hyperglycemic | [ | |
|
| sclerotia | inonotusanes A, B and C, | Extracted under reflux with 95% EtOH for 1 h, further extracted with petroleum ether, EtOAc and | Silica gel Column chromatography [petroleum ether-EtOAc (25:1 to 1:1) and then MeOH] to obtain different fractions | Antitumor and cytotoxicity | [ | |
|
| Mycelium and sclerotium | Ergosterol | Extraction in 80% ( | nd | Antitumor and cytotoxicity | [ | |
|
| |||||||
|
|
|
|
|
|
| ||
| Solid Substrate Fermentation |
| SMS | Lignocellulose-degrading enzymes | Treatment with five different solutions: distilled water, quarter-strength Ringer solution, sodium hydroxide, hydrochloric acid and potassium phosphate buffer. Incubation at 37 °C for 1 h with shaking before being clarified by centrifugation. | [ | ||
| SMS | Cellulose-degrading enzymes: Cellulases, β-glucosidase, dextranase, amylase and laccase | Samples of the compost (wet weight) were mixed with distilled water (1:10 | [ | ||||
| SMS | Lignocellulolytic Enzymes | Extracellular enzymes were extracted using four solutions | [ | ||||
| SMS | Laccase | Extraction with Buffer A, which contained 0.1 M sodium acetate, 5 mM calcium chloride, 0.05% Tween80 and 1% polyvinylpolypyrrolidone, on rotary shaker (180 rpm, 25 °C) for 1 h. The aqueous suspensions were centrifuged (11,000× | [ | ||||
|
| SMS | Laccase | The residual compost (2.0 g) was mixed with distilled water (3.0 mL). The resulting mixture was kept at 4 °C for 24 h. The solid phase was recovered and pressed manually to increase the amount of liquid phase obtained. Liquid phase was passed through a mesh (0.8 mm) and centrifuged (10,000× | [ | |||
| SMS | α-amylase, cellulase, | Suspension in 100 mL of 6 solutions: 1% ( | [ | ||||
| Submerged Liquid Fermentation |
| Submerged culture supernatant | Fibrinolytic enzymes | After fermentation, the broth was centrifuged at 9700× | [ | ||
nd—not determined.
List of non-authorized and authorized health claims for bioactive compounds that may be present in mushrooms.
| Health claims | Mushroom Specie/Compound | Health Claim | Health Effect |
|---|---|---|---|
| Non-authorized |
| Stimulates the body in exhaustion | Physical well-being |
|
| Contributes to natural immunological defenses | Stimulation of immunological responses | |
|
| Regulates physiology of pancreas and fat metabolism | Improvement of the digestion of macronutrients (e.g., carbohydrates, proteins and lipids) | |
|
| Antioxidants can protect from radicals which cause cell damage; antioxidants can protect cells and tissues from oxidative damage. | Protection of DNA, proteins and lipids from oxidative damage. | |
| Contributes to natural immunological defenses. | Immune function/immune system. | ||
| Authorized | Beta-glucan | Beta-glucans contribute to the maintenance of normal blood cholesterol levels; | Maintenance of normal blood cholesterol concentrations. |
| Chitosan | Chitosan contributes to the maintenance of normal blood cholesterol levels. | Maintenance of normal blood LDL-cholesterol concentrations. | |
| Plant sterols and plant stanols | Plant sterols/stanols contribute to the maintenance of normal blood cholesterol levels. | Maintenance of normal blood cholesterol concentrations. |